Skip to content

Adefovir for hep B: not an HIV resistance risk

Resistance after nevirapine prophylaxis appears more common in women with HIV subtype D

Transmission of unusual HIV variants may increase risk of treatment failure

Evidence of 3TC resistance after treatment interruptions

Fifth Resistance Workshop Begins In Scottsdale, Arizona

Immune based therapies: Australian studies highlight new approaches

Late diagnoses a problem in the UK

New European resistance testing guidelines

Africans still being diagnosed later in the UK